[go: up one dir, main page]

Chen et al., 1994 - Google Patents

THE EFFICACY OF NON-LACTATE-GENERATING METABOLITES AS SUBSTRATES FOR MAINTAINING DONOR TISSUES1

Chen et al., 1994

Document ID
3837226203899162835
Author
Chen C
Chen S
Publication year
Publication venue
Transplantation

External Links

Snippet

The study was conducted to investigate effectiveness of non-lactate-generating metabolites as substrates for maintaining donor tissues.[beta]-hydroxybutyrate was selected for the study, with the cornea as the experimental model. Parameters included the effect on growth …
Continue reading at journals.lww.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
DE69914160T2 (en) Defined medical solution without serum for ophthalmology
US5116868A (en) Effective ophthalmic irrigation solution
Christen et al. Trout sperm motility: the transient movement of trout sperm is related to changes in the concentration of ATP following the activation of the flagellar movement
RU2199310C2 (en) Solution and method for revivification and restoration of ischemically affected tissue
Heyliger et al. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats
DE69114485T2 (en) Defined medical solution without serum and its use.
Glasser et al. Effects of intraocular irrigating solutions on the corneal endothelium after in vivo anterior chamber irrigation
US8691571B1 (en) Extending tissue preservation
Taylor Biology of cell survival in the cold: the basis for biopreservation of tissues and organs
Kuang et al. Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium
Lemasters et al. Reperfusion injury to heart and liver cells: protection by acidosis during ischemia and a “pH paradox” after reperfusion
US20240041023A1 (en) Composition and method of preserving viability of cell in a low temperature
Frerichs Neuroprotective strategies in nature—novel clues for the treatment of stroke and trauma
Chen et al. THE EFFICACY OF NON-LACTATE-GENERATING METABOLITES AS SUBSTRATES FOR MAINTAINING DONOR TISSUES1
EP0687411B1 (en) Hepatic graft preservative composition and a method for viable preservation of the hepatic graft
Duane Metabolism of the cornea
Symons et al. Perflubron emulsion improves tolerance to low-flow ischemia in isolated rabbit hearts
Abd-Elfattah et al. Inhibition of adenosine deaminase and nucleoside transport: utility in a model of homograft cardiac valve preimplantation processing
Fuller Organ preservation: The profit and loss account of using hypothermia to maintain viability
US11213026B2 (en) Solution for preserving and/or rinsing an organ to be transplanted
TWI388318B (en) Carnitine-containing peritoneal dialysis solution having improved biocompatibility
CN1314810A (en) Perfusate preparations for ophthalmic surgery
JPH0733601A (en) Composition for tissue preservation
KINSEY PHYSIOLOGIC CHEMISTRY OF THE EYE: A Review of Papers Published During 1951
Cooperstein et al. Effects of ascorbate and ATP upon amino acid transport in the toad's cornea.